Results 161 to 170 of about 546,164 (358)

Current Status of the Infrastructure and Characteristics of Radiation Oncology in Korea [PDF]

, 2007
Seung Jae Huh
openalex   +1 more source

Gender equality and leadership in radiation oncology research: a plea to women to come forward

, 2023
Corinne Faivre‐Finn
openalex   +1 more source

Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality‐of‐Life Analysis [PDF]

, 2020
Molly Havard, Hope Esslinger, Michelle Mierzwa, Jordan Kharofa, Vinita Takiar   +4 more
openalex   +1 more source

American Society for Radiation Oncology's Advances in Radiation Oncology in 2022

Advances in Radiation Oncology, 2022
Miller, Robert C., Tsai, C. Jillian
openaire   +2 more sources

LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1

Advanced Science, EarlyView.
LMO7 in tumor‐associated macrophages suppresses phagocytosis of tumor cells and limits cytotoxic T lymphocytes infiltration, fostering tumor progression. Mechanistically, LMO7 mediates the ubiquitination and degradation of the phagocytic receptor LRP1, impairing its ability to engulf tumor cells and driving macrophages toward an antitumor phenotype ...
Mengkai Li, Tao Wang, Yuwen Zhong, Zhiming Wang, Wei Li, Zejian Wang, Xinyi Yang, Yu Qiao, Jianfeng Xiang, Wei Gu, Zishu Wang, Lei Sun, Feng Qian   +12 more
wiley   +1 more source

Radiation-Induced Liver Injury: An Overview

Journal of Hepatocellular Carcinoma
Jing Sun,1,* Hao-ran Lu,1,* Jian-hui Wu,2,* Dong Li,1,* Tao Zhang,1 Xue-zhang Duan1 1Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s ...
Sun J, Lu HR, Wu JH, Li D, Zhang T, Duan XZ   +5 more
doaj  

IHE-RO: Assessing the Status of Re-planning in Radiation Oncology [PDF]

, 2010
C Able, C.J. Hampton, Anil Sethi, M. Mizaei-McKee, Kevin Albuquerque   +4 more
openalex   +1 more source

KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression

Advanced Science, EarlyView.
Cholangiocarcinoma (CCA) driven by oncogenic KRAS depends on its continuous activation for tumor maintenance. Using a conditional KRAS model, the authors show that turning off KRAS triggers rapid tumor regression accompanied by immune cell infiltration and cytokine release. The findings uncover a KRAS–senescence–immune signaling axis and highlight KRAS
Youwei Qiao, Matthew F. Yee, Chaitanya N. Parikh, Boyang Ma, Yueying Cao, Yu‐Huan Shih, Joae Qiong Wu, Marcus Ruscetti, Shun‐Qing Liang, Wen Xue   +9 more
wiley   +1 more source

Safety and Efficacy of Serplulimab Combined with Neoadjuvant Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer: A Retrospective Study

Cancer Management and Research
Meng Tian,1,2,* Minghui Zhao,2,* Linhong Jiang,2,* Jia Liu,2,* Gefenqiang Shen,2 Zhaoyue Zhang,2,3 Caiqiang Zhu,1 Sheng Zhang,2 Xinchen Sun,2 Yujing Shi,1 Xiaoke Di1,2 1Department of Oncology, Jurong Hospital Affiliated to
Tian M, Zhao M, Jiang L, Liu J, Shen G, Zhang Z, Zhu C, Zhang S, Sun X, Shi Y, Di X   +10 more
doaj  

Guardians of Sensation: Evaluating Metformin’s Power Against Chemotherapy-Induced Neuropathy

International Journal of Breast Cancer
Conclusion: Metformin may modestly reduce the incidence of CIPN in patients receiving paclitaxel chemotherapy, although the observed effect was not statistically significant.
Hamid Nasrolahi, Ahmad Mosalaei, Susan Andalibi, Shapour Omidvari, Mansour Ansari, Mohammad Mohammadianpanah, Niloofar Ahmadloo, Samineh Sadeghian, Afshin Karimzadeh, Ehsan Mohammad Hosseini   +9 more
doaj   +1 more source